Clinical trial
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
NCT00791037
Study timeline
Study start (unknown)2008-10-01Date precision: month
Registry last updated2017-05-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HER2-positive Breast Cancerunresolved
Male Breast Cancerunresolved
Recurrent Breast Cancerunresolved
Stage IV Breast Cancerunresolved
Interventions
HER-2/neu peptide vaccineBIOLOGICAL
leukapheresisPROCEDURE
ex vivo-expanded HER2-specific T cellsBIOLOGICAL
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
sargramostimBIOLOGICAL
Sponsors & collaborators
University of Washingtonlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00791037 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.